COLISTIN

( DrugBank: Colistin / KEGG DRUG: Colistin )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
299	嚢胞性線維症	26

299. 嚢胞性線維症

臨床試験数 : 1,695 / 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174

trials per page:

Showing 1 to 10 of 26 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02894684 (ClinicalTrials.gov)	January 2017	1/9/2016	Aztreonam for Inhalation Solution (AZLI) for the Treatment of Exacerbations of Cystic Fibrosis	Aztreonam for Inhalation Solution (AZLI) for the Treatment of Exacerbations of Cystic Fibrosis. An R ...	Cystic Fibrosis;Infection;Pseudomonas	Drug: Aztreonam;Drug: Standard Care	Liverpool Heart and Chest Hospital NHS Foundation Trust	University of Liverpool	Completed	16 Years	65 Years	Male	16	Phase 4	United Kingdom
2	EUCTR2016-002832-34-GB (EUCTR)	11/11/2016	03/10/2016	The use of an inhaled antibiotic called Cayston to treat acute chest infections in people with CF	Aztreonam for inhalation for the treatment of acute exacerbations in cystic fibrosis. An open-label, ...	Cystic fibrosis MedDRA version: 19.0;Level: PT;Classification code 10011762;Term: Cystic fibrosis;Sy ...	Trade Name: Cayston Product Name: Cayston INN or Proposed INN: Aztreonam Other descriptive name: Caysto ...	Liverpool Heart & Chest Hospital	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	16	Phase 4	United Kingdom
3	EUCTR2016-001785-29-IE (EUCTR)	15/08/2016	10/05/2016	Study of the effects of combined treatment with the CFTR corrector ivacaftor and IV antibiotics on i ...	Combined Effect of CFTR Modifiers and Intensive Antibiotic Treatment	Cystic fibrosis;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]	Trade Name: Kalydeco INN or Proposed INN: IVACAFTOR Trade Name: Ciprofloxacin INN or Proposed INN: Cipr ...	St. Vincent's University Hospital	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes		Phase 4	Ireland
4	NCT02918409 (ClinicalTrials.gov)	August 2016	12/4/2016	IV Colistin for Pulmonary Exacerbations: Improving Safety and Efficacy	IV Colistin for Pulmonary Exacerbations: Improving Safety and Efficacy	Cystic Fibrosis	Drug: Colistin;Drug: Tobramycin	National Jewish Health	NULL	Active, not recruiting	18 Years	N/A	All	51	Phase 4	United States
5	EUCTR2015-003881-96-IT (EUCTR)	17/05/2016	05/11/2020	Clinical study to assess two different Pseudomonas aeruginosa eradication protocols in patients with ...	Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study ...	cystic fibrosis MedDRA version: 20.0;Level: PT;Classification code 10011762;Term: Cystic fibrosis;Sy ...	Trade Name: COLIMICINA - 1000000 U/4 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO INTRAMU ...	AZIENDA OSPEDALIERO-UNIVERSITARIA MEYER	NULL	Not Recruiting			Female: yes Male: yes	112	Phase 3	Italy
6	EUCTR2015-003662-87-DK (EUCTR)	13/11/2015	22/09/2015	Pseudomonas Aeruginosa - Inhalation treatment, biomarkers and quality of life	Pseudomonas Aeruginosa - Inhalation treatment, biomarkers and quality of life - Pseudomonas, Tazocin ...	Chronic pulmonary disease patients, except cystic fibrosis patients, with confirmed pulmonary infect ...	Trade Name: colistimethate sodium (promixin) INN or Proposed INN: COLISTIMETHATE SODIUM Trade Name: Pi ...	Aarhus University Hospital, Department of Respiratory Medicine	NULL	Not Recruiting			Female: yes Male: yes		Phase 2	Denmark
7	EUCTR2012-001565-33-IE (EUCTR)	08/01/2015	11/09/2014	An open-label clinical trial that compares how long it takes in total for a patient with cystic fibr ...	An open-label, crossover, interventional Phase IV study to compare the ease of use of tobramycin inh ...	Chronic lung infection with Pseudomonas aeruginosa in cystic fibrosispatients MedDRA version: 17.0;L ...	Trade Name: TOBI Podhaler Product Name: TOBI Podhaler Product Code: TBM100C INN or Proposed INN: Tobram ...	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	67	Phase 4	Spain;Ireland;Germany;United Kingdom;Switzerland
8	EUCTR2013-004987-80-BE (EUCTR)	28/08/2014	18/02/2014	Colistin dosage through blood samples and sputum in Cystic Fibrosis (CF) population	Colistinuse in Cystic Fibrosis patients: pharmacokinetic studies (intravenous administration) in rel ...	Colistinuse in Cystic Fibrosis patients MedDRA version: 16.1;Level: PT;Classification code 10011762; ...	Trade Name: COLISTINEB 2MUI INN or Proposed INN: Colistineb Other descriptive name: COLISTIMETHATE SOD ...	CUB - Hôpital Erasme	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			Belgium
9	EUCTR2013-004295-35-AT (EUCTR)	30/04/2014	02/04/2014	Lung Clearance Index as an OUTcome parameter to detect the efficacy f Aztreonam Lysine Inhalation in ...	Lung Clearance Index as an OUTcome parameter to detect the efficacy f Aztreonam Lysine Inhalation in ...	Chronic lung P. Aeruginosa Infection MedDRA version: 16.1;Level: PT;Classification code 10061229;Ter ...	Trade Name: Cayston 75 mg Pulver und Lösungsmittel zur Herstellung einer Lösung für einen Vernebler P ...	Medical University Innsbruck - Department für Kinder- und Jugendheilkunde (Pädiatrie III)	NULL	Not Recruiting			Female: yes Male: yes	15	Phase 4	Austria
10	NCT03341741 (ClinicalTrials.gov)	March 11, 2014	3/11/2017	Combined Dry Powder Tobramycin and Nebulized Colistin Inhalation in CF Patients	Combined Dry Powder Tobramycin and Nebulized Colistin Inhalation in CF Patients	Cystic Fibrosis With Pulmonary Manifestations	Drug: Tobramycin Powder;Drug: Colistin	University Hospital Tuebingen	NULL	Completed	12 Years	N/A	All	26	Phase 3	NULL

First Previous1 2 3Next Last